Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

hiv-infected_h9_t-cell_-_credit_national_institutes_of_health-web

Kymab demonstrates promising research for HIV vaccine development

September 9, 2016 Medical Communications, Research and Development HIV, Vaccine, kymab

Cambridge-based antibodies-to-medicines company Kymab has announced publication of research testing the first step in the effort to develop effective vaccines …
News
gsk-house-location-building

GSK proposes biopreparedness unit to combat global outbreaks

September 9, 2016 Medical Communications, Research and Development Ebola, GSK, Zika

London-based pharma giant GlaxoSmithKline has proposed the creation of a biopreparedness unit to help avert crises like those we have …
News
4420456374_64a3d7e6aa

Top ten stories in the pharmaceutical industry this week

September 9, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, BMS, Celgene, Cloud Computing, Eisai, FDA, GSK, Halaven, Novartis, Novo Nordisk, Roche, Teva, agios, epipen, rheumatoid arthritis

It’s Friday, and that means it’s time for another run-down of the biggest stories on Pharmafile.com over the last week. …
News

Apple introduce stricter entry requirements for health apps

September 8, 2016 Medical Communications, Research and Development Apple, Guidelines, apps, iphone, strict

Apple has toughened its stance on health and medical apps that can be bought and downloaded on the iOS App …
News
dollars_medicines

Retrophin announces positive Phase II results, Shkreli claims credit

September 8, 2016 Research and Development Phase II, Retrophin, Shkreli, rare kidney disease

Retrophin has announced positive top-line results for trial drug sparsentan in Phase II to treat a rare kidney disorder with …
News
celgene_1_02

Celgene and Agios to file FDA application for “first-in-class” cancer drug

September 8, 2016 Research and Development, Sales and Marketing Celgene, FDA, NDA, acute myeloid leukaemia, agios

According to an SEC 8-K filing by Agios, the company and its partner Celgene intend to file a new drug …
News
takeda_tokyo_hq

Takeda begins Phase III dengue vaccine trial

September 8, 2016 Research and Development Takeda, Vaccine, dengue, dengue vaccine, phase III, trial

Takeda Pharmaceuticals has announced the initiation of a global Phase III clinical trial to test its live-attenuated tetravalent dengue vaccine …
News
c_ssilver-fotolia_ebr_jul_2014

Clinical Trial Transparency

September 8, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trial, clinical trial transparency, transparency

Amid the global political and economic turmoil taking place, one small pharma story got much less attention than it should …
Feature
merck_and_co

FDA to review MSD’s Keytruda as a first-line lung cancer treatment

September 7, 2016 Research and Development FDA, MSD, Merck, first-line, keytruda, lung cancer, non-small cell lung cancer, opdivo

The US Food and Drug Administration has accepted the supplemental biologics license application from MSD, known as Merck in the …
News
ole_isacson

Pfizer appoints new chief scientific officer for neuroscience research

September 7, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Ole Isacson has been named as the chief scientific officer at Pfizer’s neuroscience research unit. He will continue to …
Appointment
brent_saunders

Allergan CEO outlines ‘social contract with patients’

September 7, 2016 Research and Development, Sales and Marketing Allergan, Brent Saunders, CEO, blog

Highlighting a recent shift in the priorities of the pharmaceutical industry, Allergan CEO and president Brent Saunders has outlined a …
News
clinical_trial_4

Tonix tanks after Phase III failure

September 7, 2016 Research and Development PTSD, fibromylagia, phase III failure, tonix, tonix pharmaceuticals

New York-based Tonix Pharmaceuticals has suffered an almost 60% fall in their share price, after the announcement that its fibromyalgia …
News
allergan

Allergan acquires biotech Retrosense for $60 million

September 7, 2016 Research and Development, Sales and Marketing Allergan, Retrosense, acquisition

Allergan has announced that it has acquired Retrosense, a biotech focused on novel gene therapy approaches to restore vision in …
News
legal

Antitrust investigation launched into Mylan and the EpiPen scandal

September 7, 2016 Research and Development, Sales and Marketing Mylan, US, antitrust, epipen, investigation, lawmakers, scandal

The New York attorney general has commenced an investigation into Mylan Pharmaceuticals, after an initial review indicated that the company …
News
bms

European Commission approves new RA treatment from BMS

September 6, 2016 Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, EMA, EU, Orencia, RA, abatacept, approval, rheumatoid arthritis

Bristol-Myers Squibb has received approval from the European Commission for rheumatoid arthritis (RA) treatment Orencia (abatacept), making it the first …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026